Literature DB >> 24639125

Dynamic alterations of connexin43, matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 during ventricular fibrillation in canine.

Jing Wang1, Jing-sha Li, Hong-zhen Liu, Shao-lei Yi, Guo-ying Su, Yun Zhang, Jing-quan Zhong.   

Abstract

The aim of this study is to investigate the dynamic alterations of cardiac connexin 43 (Cx43), matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) in the setting of different ventricular fibrillation (VF) duration. In this study, thirty-two dogs were randomly divided into sham control group, 8-min VF group, 12-min VF group, and 30-min VF group. Cx43 and phosphorylated Cx43 (p-Cx43) in tissues were detected by western blot and immunofluorescence analysis. MMP-2 and TIMP-2 were detected by western blot and immunohistochemistry analysis. The results showed that Cx43 levels in three VF groups were significantly decreased compared with sham control group. p-Cx43 levels in 12-min and 30-min VF groups were significantly reduced compared with sham control group. The ratio of p-Cx43/Cx43 was also decreased in VF groups. Compared with sham controls, no significant difference was observed between the sham control group and 8-min VF group in MMP-2 level, but MMP-2 level increased in 12-min and 30-min VF groups. The ratios of MMP-2/TIMP-2 were higher in VF groups, and were correlated with the duration of VF. A remarkable correlation was observed between the ratio of p-Cx43/Cx43 and MMP-2/TIMP-2 (r = -0.93, P < 0.01). In conclusion, the alteration of Cx43 and/or p-Cx43 levels and the imbalance of MMP-2 and TIMP-2 may contribute to the initiation and/or persistence of VF. Maneuvers managed to modulate Cx43 level or normalize the balance of MMP-2/TIMP-2 are promising to ameliorate prognosis of VF.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24639125     DOI: 10.1007/s11010-014-2012-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

1.  Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.

Authors:  S Hinan Ahmed; Leslie L Clark; Weems R Pennington; Carson S Webb; D Dirk Bonnema; Amy H Leonardi; Catherine D McClure; Francis G Spinale; Michael R Zile
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

2.  Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs.

Authors:  James K Hennan; Robert E Swillo; Gwen A Morgan; James C Keith; Robert G Schaub; Robert P Smith; Hal S Feldman; Ketil Haugan; Joel Kantrowitz; Phil J Wang; Aqel Abu-Qare; John Butera; Bjarne D Larsen; David L Crandall
Journal:  J Pharmacol Exp Ther       Date:  2005-12-12       Impact factor: 4.030

3.  Release of gelatinase A during platelet activation mediates aggregation.

Authors:  G Sawicki; E Salas; J Murat; H Miszta-Lane; M W Radomski
Journal:  Nature       Date:  1997-04-10       Impact factor: 49.962

4.  Changes in connexin 43, metalloproteinase and tissue inhibitor of metalloproteinase during tachycardia-induced cardiomyopathy in dogs.

Authors:  Jing-quan Zhong; Wei Zhang; Haiqing Gao; Yan Li; Ming Zhong; Duoling Li; Cheng Zhang; Yun Zhang
Journal:  Eur J Heart Fail       Date:  2006-07-07       Impact factor: 15.534

5.  Imbalanced circulating matrix metalloproteinases in polycystic ovary syndrome.

Authors:  Valéria A Gomes; Carolina S Vieira; Anna L Jacob-Ferreira; Vanessa A Belo; Gustavo M Soares; Janaína B F Fernandes; Rui A Ferriani; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2011-03-25       Impact factor: 3.396

6.  CX43 change in LPS preconditioning against apoptosis of mesenchymal stem cells induced by hypoxia and serum deprivation is associated with ERK signaling pathway.

Authors:  Jun Wang; Zhi Li; Yangyang Zhang; Xiang Liu; Liang Chen; Yijiang Chen
Journal:  Mol Cell Biochem       Date:  2013-05-28       Impact factor: 3.396

7.  Reversible connexin 43 dephosphorylation during hypoxia and reoxygenation is linked to cellular ATP levels.

Authors:  Mark S Turner; Guy A Haywood; Peter Andreka; Lijing You; Patricia E Martin; W Howard Evans; Keith A Webster; Nanette H Bishopric
Journal:  Circ Res       Date:  2004-09-09       Impact factor: 17.367

8.  Retinoic acid regulates gap junction intercellular communication in human endometrial stromal cells through modulation of the phosphorylation status of connexin 43.

Authors:  Juanjuan Wu; Robert N Taylor; Neil Sidell
Journal:  J Cell Physiol       Date:  2013-04       Impact factor: 6.384

9.  Early repair of moderate ischemic mitral regurgitation reverses left ventricular remodeling: a functional and molecular study.

Authors:  Ronen Beeri; Chaim Yosefy; J Luis Guerrero; Suzan Abedat; Mark D Handschumacher; Robert E Stroud; Suzanne Sullivan; Miguel Chaput; Dan Gilon; Gus J Vlahakes; Francis G Spinale; Roger J Hajjar; Robert A Levine
Journal:  Circulation       Date:  2007-09-11       Impact factor: 29.690

10.  Hypoxia induces connexin 43 dysregulation by modulating matrix metalloproteinases via MAPK signaling.

Authors:  Xianghong Wu; Wen Huang; Gang Luo; Laval Andy Alain
Journal:  Mol Cell Biochem       Date:  2013-09-04       Impact factor: 3.396

View more
  2 in total

Review 1.  Intracellular Cleavage of the Cx43 C-Terminal Domain by Matrix-Metalloproteases: A Novel Contributor to Inflammation?

Authors:  Marijke De Bock; Nan Wang; Elke Decrock; Geert Bultynck; Luc Leybaert
Journal:  Mediators Inflamm       Date:  2015-09-03       Impact factor: 4.711

Review 2.  Antagonistic Functions of Connexin 43 during the Development of Primary or Secondary Bone Tumors.

Authors:  Julie Talbot; Maryne Dupuy; Sarah Morice; Françoise Rédini; Franck Verrecchia
Journal:  Biomolecules       Date:  2020-08-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.